• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Tuesday, November 25, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Lines blurring between human herpes simplex viruses

Bioengineer by Bioengineer
April 30, 2019
in Health
Reading Time: 2 mins read
0
IMAGE
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

HSV-1, which mostly infects the mouth, and HSV-2, which causes genital sores, are forming recombinants in present-day humans

IMAGE

Credit: Greg Pepper

The line between the human herpes simplex viruses – HSV-1 and HSV-2 – is blurrier than previously thought, according to a new study published this week in the Journal of Infectious Diseases.

Researchers found that HSV-1 and HSV-2 are mixing together to result in several new, different recombinant versions of herpes.

“The main implication is that HSV-1 and HSV-2 are continuing to recombine,” said lead author Dr. Amanda Casto, a senior fellow in infectious diseases at the University of Washington School of Medicine. “This could have important implications for HSV vaccine development, because it means a live HSV-2 vaccine could recombine with circulating HSV-1 strains, thereby forming an infectious virus.”

HSV-1 and HSV-2 are two of the most common viruses affecting people. Moreover, humans are the only mammals that have two types of herpes simplex viruses.

Both viruses look alike clinically and are sensitive to the same drug, acyclovir. But they are genetically different. HSV-1 most commonly affects the mouth, while HSV-2 usually causes genital lesions.

More than two-thirds of the world’s population is estimated to be infected with one or both viruses, according to the World Health Organization

Both HSV-1 and HSV-2 cause incurable, lifelong infections. These infections can be completely asymptomatic or lead to intermittent symptoms, which can be treated with medications.

Not much progress, however, has been made in preventing herpes.

“Herpes is one of the most stigmatized diseases out there, and yet it affects billions of people,” said co-author Dr. Alexander Greninger, assistant professor of laboratory medicine at the University of Washington School of Medicine and assistant director of the UW Medicine Clinical Virology Laboratory. “We really need more work to combat this virus.”

Casto explained that HSV-1 and HSV-2 diverged from one virus some 6 million years ago when humans diverged from chimps. After HSV-2 jumped back into humans about 1.6 million years ago, humans were left with two types of herpes simplex viruses. While there is evidence suggesting ancient recombination between HSV-1 and HSV-2, this study finds evidence for on-going recombination in humans today.

Though HSV-1 classically causes oral lesions and HSV-2 genital lesions, genital herpes due to HSV-1 is becoming increasingly common. The authors speculate that by leading to more genital HSV-1/HSV-2 coinfections this trend could result in the creation of more HSV-1/HSV-2 recombinant viruses.

In an accompanying editorial, Dr. Scott Schmid of the Centers for Disease Control and Prevention, Division of Viral Diseases, said the study greatly expands knowledge of these viruses.

“These fascinating new insights into the dynamic interaction between two common human herpesvirus infections provide fresh concepts into how these complex viruses can maximize variation and thus continue their eons-old balance of power with their hosts,” he wrote.

###

Media Contact
Leila Gray
[email protected]

Related Journal Article

http://dx.doi.org/10.1093/infdis/jiz199

Tags: GenesInfectious/Emerging DiseasesMedicine/HealthPublic HealthSex-Linked ConditionsSexual BehaviorVaccinesVirology
Share13Tweet8Share2ShareShareShare2

Related Posts

Zinc Finger Nuclease Revives Paternal UBE3A in Mice

November 25, 2025

Silencing PCSK9 Boosts Safe, Effective Cancer Immunotherapy

November 25, 2025

Exploring Online Health Information and Medicine Choices

November 25, 2025

Tracing Forensic Age Estimation: 2002-2024 Trends

November 25, 2025
Please login to join discussion

POPULAR NEWS

  • New Research Unveils the Pathway for CEOs to Achieve Social Media Stardom

    New Research Unveils the Pathway for CEOs to Achieve Social Media Stardom

    203 shares
    Share 81 Tweet 51
  • Scientists Uncover Chameleon’s Telephone-Cord-Like Optic Nerves, A Feature Missed by Aristotle and Newton

    119 shares
    Share 48 Tweet 30
  • Neurological Impacts of COVID and MIS-C in Children

    93 shares
    Share 37 Tweet 23
  • Scientists Create Fast, Scalable In Planta Directed Evolution Platform

    99 shares
    Share 40 Tweet 25

About

BIOENGINEER.ORG

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Laser-Driven Electron Acceleration in Carbon Nanotube Targets

Zinc Finger Nuclease Revives Paternal UBE3A in Mice

Silencing PCSK9 Boosts Safe, Effective Cancer Immunotherapy

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 69 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.